Graham Capital Management L.P. Buys Shares of 11,650 Phibro Animal Health Co. (NASDAQ:PAHC)

Graham Capital Management L.P. bought a new position in Phibro Animal Health Co. (NASDAQ:PAHC - Free Report) during the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm bought 11,650 shares of the company's stock, valued at approximately $245,000.

A number of other large investors have also made changes to their positions in PAHC. Vanguard Group Inc. boosted its holdings in shares of Phibro Animal Health by 1.4% in the fourth quarter. Vanguard Group Inc. now owns 1,514,736 shares of the company's stock worth $31,809,000 after buying an additional 20,604 shares during the last quarter. American Century Companies Inc. raised its position in Phibro Animal Health by 18.0% in the fourth quarter. American Century Companies Inc. now owns 635,599 shares of the company's stock worth $13,348,000 after acquiring an additional 96,787 shares during the period. Renaissance Technologies LLC boosted its stake in shares of Phibro Animal Health by 1.9% during the 4th quarter. Renaissance Technologies LLC now owns 557,800 shares of the company's stock worth $11,714,000 after acquiring an additional 10,600 shares during the last quarter. Geode Capital Management LLC grew its position in shares of Phibro Animal Health by 1.7% during the 4th quarter. Geode Capital Management LLC now owns 515,979 shares of the company's stock valued at $10,838,000 after acquiring an additional 8,510 shares during the period. Finally, CastleKnight Management LP grew its position in shares of Phibro Animal Health by 6.2% during the 4th quarter. CastleKnight Management LP now owns 389,433 shares of the company's stock valued at $8,178,000 after acquiring an additional 22,796 shares during the period. 99.34% of the stock is currently owned by institutional investors.

Phibro Animal Health Price Performance

NASDAQ:PAHC opened at $24.00 on Monday. The business's 50-day simple moving average is $20.08 and its two-hundred day simple moving average is $21.85. Phibro Animal Health Co. has a 52 week low of $16.16 and a 52 week high of $26.55. The stock has a market cap of $972.82 million, a PE ratio of 50.00, a P/E/G ratio of 0.45 and a beta of 0.62. The company has a quick ratio of 1.37, a current ratio of 3.20 and a debt-to-equity ratio of 2.99.

Phibro Animal Health (NASDAQ:PAHC - Get Free Report) last issued its earnings results on Wednesday, May 7th. The company reported $0.63 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.52 by $0.11. Phibro Animal Health had a return on equity of 25.35% and a net margin of 1.75%. The company had revenue of $347.80 million for the quarter, compared to the consensus estimate of $352.41 million. As a group, analysts forecast that Phibro Animal Health Co. will post 1.95 EPS for the current fiscal year.

Phibro Animal Health Dividend Announcement

The business also recently announced a quarterly dividend, which will be paid on Wednesday, June 25th. Stockholders of record on Wednesday, June 4th will be issued a $0.12 dividend. This represents a $0.48 annualized dividend and a dividend yield of 2.00%. The ex-dividend date is Wednesday, June 4th. Phibro Animal Health's dividend payout ratio (DPR) is presently 61.54%.

Wall Street Analysts Forecast Growth

PAHC has been the topic of a number of recent research reports. Morgan Stanley lifted their target price on Phibro Animal Health from $20.00 to $21.00 and gave the company an "equal weight" rating in a research report on Thursday, May 8th. StockNews.com raised Phibro Animal Health from a "hold" rating to a "buy" rating in a research report on Friday, May 9th. Finally, Barclays boosted their price objective on Phibro Animal Health from $20.00 to $22.00 and gave the company an "underweight" rating in a research note on Monday, February 10th. Two equities research analysts have rated the stock with a sell rating, two have assigned a hold rating and one has assigned a buy rating to the company. Based on data from MarketBeat, Phibro Animal Health presently has an average rating of "Hold" and an average price target of $20.00.

Phibro Animal Health Company Profile

Phibro Animal Health Corporation operates as an animal health and mineral nutrition company in the United States, Israel, Brazil, Ireland, and internationally. It operates through three segments: Animal Health, Mineral Nutrition, and Performance Products. The company develops, manufactures, and markets various products for food and companion animals including poultry, swine, beef and dairy cattle, aquaculture, and dogs.

Want to see what other hedge funds are holding PAHC? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Phibro Animal Health Co. (NASDAQ:PAHC - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.